Results 91 to 100 of about 39,721 (242)

Possible hepatotoxic consequence of nevirapine use in juvenile albino rats [PDF]

open access: yesJournal of Pharmacy & Pharmacognosy Research, 2017
Context: Nevirapine (NVP) is used in human immunodeficiency virus exposed neonates. This could present safety concern due to decreased liver metabolizing enzymes activity and renal clearance in neonates.
Elias Adikwu, Bonsome Bokolo
doaj  

Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients

open access: yesPLoS ONE, 2015
Effective antiretroviral (ARV) therapy depends on adequate drug exposure, yet methods to assess ARV exposure are limited. Concentrations of ARV in hair are the product of steady-state pharmacokinetics factors and longitudinal adherence.
Sanjiv M. Baxi   +10 more
semanticscholar   +1 more source

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

open access: yesHIV Medicine, Volume 27, Issue 1, Page 18-32, January 2026.
Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni   +19 more
wiley   +1 more source

Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana

open access: yesThe Pan African Medical Journal, 2018
INTRODUCTION: Although combined Anti-Retroviral Therapy (cART) has improved the quality of life and survival in people living with HIV-AIDS (PLWHA), there have been reports of increased non-AIDS related co-morbidities such as coagulopathies.
Richard Kobina Dadzie Ephraim   +6 more
doaj   +1 more source

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine

open access: yesMolecules, 2013
Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used against HIV-1. Currently, NVP is the most widely used anti-HIV drug in developing countries, both in combination therapy and to prevent mother-to-child transmission of HIV.
M. Matilde Marques   +4 more
doaj   +1 more source

Association of CD4+ T Lymphocyte Cell Count and Viral Load With Urinary Bacterial Growth and Antimicrobial Resistance Pattern of Bacterial Isolates Among HIV Patients in Ho Municipality, Ghana: A Cross‐Sectional Study

open access: yesAIDS Research and Treatment, Volume 2026, Issue 1, 2026.
Background and Objective Human immunodeficiency virus (HIV) infection leads to a gradual decline in immune function, increasing vulnerability to opportunistic infections, including urinary bacterial growth (UBG). In immunocompromised individuals, asymptomatic UBG may develop into symptomatic infection.
Newton Kuubabongnaa   +2 more
wiley   +1 more source

Nevirapine induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human Immunodeficiency Virus positive patient

open access: yesIndian Dermatology Online Journal, 2014
Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) is one of the important components of highly active antiretroviral therapy. It is sometimes associated with life-threatening adverse reactions.
Leelavathy Budamakuntla   +4 more
doaj   +1 more source

Evaluation of HIV counseling and testing in ANC settings and adherence to short course antiretroviral prophylaxis for PMTCT in Francistown, Botswana [PDF]

open access: yes, 2009
Worldwide, it is estimated that two million children are infected with HIV (USAID 2005). The vast majority of these infections are the result of mother-to-child transmission (MTCT) of the virus during pregnancy, labor, or breastfeeding.
Carolyn Baek   +5 more
core   +1 more source

Magnitude and Predictors of Leukopenia and Thrombocytopenia in Adults With HIV/AIDS Attending Mizan Tepi University Teaching Hospital, Southwest Ethiopia

open access: yesBioMed Research International, Volume 2026, Issue 1, 2026.
Background Leukopenia and thrombocytopenia are common hematological problems among individuals living with human immunodeficiency virus (HIV/AIDS), with a reported prevalence of 6%–43.4%. Despite their clinical and public health significance, there is a limited number of studies done on their magnitude and associated predictors.
Samuel Sahile Kebede   +5 more
wiley   +1 more source

Chemical and Toxicological Analysis of Antiretroviral Drugs

open access: yesРазработка и регистрация лекарственных средств, 2019
Introduction. Human Immunodeficiency Virus (HIV) is one of the main socially significant infection all over the world. HIV-positive patients take medical care, including antiretroviral drugs (ARVs) pharmacotherapy.
T. N. Komarov   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy